Chris Sheldon, AstraZeneca's former VP and head of investor relations

As­traZeneca files law­suit against for­mer ex­ec as he jumps to GSK

As­traZeneca and GSK are once again wran­gling over tal­ent.

The British phar­ma gi­ant has filed suit against for­mer VP and head of in­vestor re­la­tions Chris Shel­don as he pre­pares to start a new job at its ri­val next month. As­traZeneca ar­gued in a Lon­don court fil­ing that Shel­don would be vi­o­lat­ing a non-com­pete agree­ment, which he was paid more than $774,000 in shares to sign back in 2021, Bloomberg re­port­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.